查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1722653

2025-2033年癌症惡病質市場（依治療、作用方式、配銷通路及地區）報告

Cancer Cachexia Market Report by Therapeutics, Mode of Action, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 134 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球癌症惡病質市場規模達 22 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 30 億美元，2025-2033 年期間的成長率 (CAGR) 為 3.9%。推動市場發展的因素包括全球癌症發病率的上升、對惡病質對患者預後重大影響的認知的不斷加深以及針對性治療研究的不斷增加，所有這些都旨在提高患者的生活品質和治療效果。

癌症惡病質是指一種多因素、宿主吞噬細胞消耗症候群，其特徵是系統性發炎、非自願性瘦體重損失、蛋白質負平衡、食慾不振和肌肉萎縮。它是由於各種慢性疾病的發生引起的，包括結核病（TB）、多發性硬化症、慢性阻塞性肺病（COPD）和人類免疫缺陷病毒（HIV）。癌症惡病質可以利用各種療法來治療，例如黃體素、皮質類固醇和聯合療法。其中，黃體素是一種合成或天然的類固醇激素，可以改善食慾並促進體重增加，而皮質類固醇有助於減輕發炎和抑制過度活躍的免疫系統。

癌症惡病質市場趨勢：

癌症和惡病質的盛行率不斷上升，尤其是在老年人口不斷增加的情況下，這促進了對先進治療方法和藥物的需求，反過來又主要推動了市場成長。消費者對治療癌症惡病質的新型治療藥物的認知不斷提高，進一步證實了這一點。此外，患者透過藥物治療、非藥物治療和臨床試驗逐漸傾向於採用聯合療法來改善瘦體重（LBM），這也是另一個促進生長的因素。同時，廣泛使用多種食慾促效劑（如醋酸甲地孕酮、地塞米松和甲基潑尼松龍）來改善消化，也促進了市場的成長。此外，強調開發治療癌症惡病質的有效藥物的重大技術進步正在進一步推動市場成長。除此之外，各國政府機構和非政府組織（NGO）正在採取許多有利舉措，讓人們了解癌症惡病質的原因、症狀以及使用先進治療方法的好處，這為市場創造了積極的前景。

本報告回答的關鍵問題

  • 2024 年全球癌症惡病質市場規模？ 2025 年至 2033 年期間全球癌症惡病質市場的預期成長率為何？
  • 推動全球癌症惡病質市場的關鍵因素有哪些？
  • COVID-19 對全球癌症惡病質市場有何影響？
  • 根據治療方法，全球癌症惡病質市場如何分佈？
  • 根據作用方式，全球癌症惡病質市場如何分佈？
  • 全球癌症惡病質市場的主要地區有哪些？
  • 全球癌症惡病質市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球癌症惡病質市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：按治療學

  • 黃體素
  • 皮質類固醇
  • 合併治療
  • 其他

第7章：市場區隔：依行動模式

  • 食慾促效劑
  • 減肥穩定劑

第8章：市場區隔：按配銷通路

  • 醫院商店
  • 零售藥局
  • 網路藥局

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AAVogen Inc.
    • Actimed Therapeutics Ltd.
    • Aphios Corporation
    • Artelo Biosciences Inc.
    • AVEO Pharmaceuticals Inc.
    • Fresenius Kabi AG (Fresenius SE & Co. KGaA)
    • Helsinn Healthcare SA
    • Merck & Co. Inc.
    • NGM Biopharmaceuticals Inc.
    • Pfizer Inc.
    • Tetra Bio-Pharma
Product Code: SR112025A5338

The global cancer cachexia market size reached USD 2.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.0 Billion by 2033, exhibiting a growth rate (CAGR) of 3.9% during 2025-2033. The market is driven by the rising global cancer incidence, the growing recognition of cachexia's significant impact on patient outcomes, and increased research into targeted therapies, all of which aim to enhance patient quality of life and treatment effectiveness.

Cancer cachexia refers to a multifactorial, host-phagocytic, wasting syndrome that is characterized by systematic inflammation, involuntary loss of lean body mass, negative protein balance, loss of appetite and muscle atrophy. It is caused due to the occurrence of various chronic diseases, including tuberculosis (TB), multiple sclerosis, chronic obstructive pulmonary disease (COPD) and human immunodeficiency virus (HIV). Cancer cachexia can be treated with the utilization of various therapeutics, such as progestogen, corticosteroid, and combination therapy. Amongst these, a progestogen is a synthetic or natural steroid hormone that improves appetite and promotes weight gain, whereas corticosteroid assists in mitigating inflammation and suppressing overactive immune systems.

Cancer Cachexia Market Trends:

The increasing prevalence of cancer and cachexia, especially amongst the rising geriatric populations, is facilitating the demand for advanced therapeutic treatment and drugs, which in turn, is primarily driving the market growth. This is further supported by the increasing awareness amongst consumers regarding the availability of novel therapeutic drugs to treat cancer cachexia. Additionally, the shifting inclination of patients toward combinational therapies for improving lean body mass (LBM) through pharmacological, non-pharmacological therapies and clinical trials is acting as another growth-inducing factor. In line with this, the extensive utilization of several appetite stimulants, such as megestrol acetate, dexamethasone, and methylprednisolone, for improving digestion is also contributing to the market growth. Moreover, significant technological advancements that are emphasizing on the development of effective medicines for cancer cachexia treatment are further propelling the market growth. Apart from this, the numerous favorable initiatives being undertaken by the government bodies of various countries and non-governmental organizations (NGOs) for sensitizing people regarding the causes of cancer cachexia, their symptoms and benefits of using advanced treatments are creating a positive outlook for the market.

Key Market Segmentation:

Breakup by Therapeutics:

  • Progestogens
  • Corticosteroids
  • Combination Therapy
  • Others

Breakup by Mode of Action:

  • Appetite Stimulators
  • Weight Loss Stabilizers

Breakup by Distribution Channel:

  • Hospital Stores
  • Retail Pharmacy
  • Online Pharmacy

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AAVogen Inc., Actimed Therapeutics Ltd., Aphios Corporation, Artelo Biosciences Inc., AVEO Pharmaceuticals Inc., Fresenius Kabi AG (Fresenius SE & Co. KGaA), Helsinn Healthcare SA, Merck & Co. Inc., NGM Biopharmaceuticals Inc., Pfizer Inc. and Tetra Bio-Pharma.

Key Questions Answered in This Report

  • 1.What was the size of the global cancer cachexia market in 2024?
  • 2.What is the expected growth rate of the global cancer cachexia market during 2025-2033?
  • 3.What are the key factors driving the global cancer cachexia market?
  • 4.What has been the impact of COVID-19 on the global cancer cachexia market?
  • 5.What is the breakup of the global cancer cachexia market based on the therapeutics?
  • 6.What is the breakup of the global cancer cachexia market based on the mode of action?
  • 7.What are the key regions in the global cancer cachexia market?
  • 8.Who are the key players/companies in the global cancer cachexia market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cancer Cachexia Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Therapeutics

  • 6.1 Progestogens
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Corticosteroids
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Combination Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Mode of Action

  • 7.1 Appetite Stimulators
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Weight Loss Stabilizers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Stores
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AAVogen Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Actimed Therapeutics Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Aphios Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Artelo Biosciences Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 AVEO Pharmaceuticals Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Fresenius Kabi AG (Fresenius SE & Co. KGaA)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Helsinn Healthcare SA
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Merck & Co. Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 NGM Biopharmaceuticals Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Pfizer Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Tetra Bio-Pharma
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: Cancer Cachexia Market: Major Drivers and Challenges
  • Figure 2: Global: Cancer Cachexia Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Cancer Cachexia Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Cancer Cachexia Market: Breakup by Therapeutics (in %), 2024
  • Figure 5: Global: Cancer Cachexia Market: Breakup by Mode of Action (in %), 2024
  • Figure 6: Global: Cancer Cachexia Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Cancer Cachexia Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Cancer Cachexia (Progestogens) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Cancer Cachexia (Progestogens) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Cancer Cachexia (Corticosteroids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Cancer Cachexia (Corticosteroids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Cancer Cachexia (Combination Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Cancer Cachexia (Combination Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Cancer Cachexia (Other Therapeutics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Cancer Cachexia (Other Therapeutics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Cancer Cachexia (Appetite Stimulators) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Cancer Cachexia (Appetite Stimulators) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Cancer Cachexia (Weight Loss Stabilizers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Cancer Cachexia (Weight Loss Stabilizers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Cancer Cachexia (Hospital Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Cancer Cachexia (Hospital Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Cancer Cachexia (Retail Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Cancer Cachexia (Retail Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Cancer Cachexia (Online Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Cancer Cachexia (Online Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Cancer Cachexia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Cancer Cachexia Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Cancer Cachexia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Cancer Cachexia Industry: SWOT Analysis
  • Figure 76: Global: Cancer Cachexia Industry: Value Chain Analysis
  • Figure 77: Global: Cancer Cachexia Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cancer Cachexia Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Cancer Cachexia Market Forecast: Breakup by Therapeutics (in Million USD), 2025-2033
  • Table 3: Global: Cancer Cachexia Market Forecast: Breakup by Mode of Action (in Million USD), 2025-2033
  • Table 4: Global: Cancer Cachexia Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Cancer Cachexia Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Cancer Cachexia Market: Competitive Structure
  • Table 7: Global: Cancer Cachexia Market: Key Players